|
1
|
Perera M, Al-Hebshi NN, Perera I, Ipe D,
Ulett GC, Speicher DJ, Chen T and Johnson NW: Inflammatory
bacteriome and oral squamous cell carcinoma. J Dent Res.
97:725–732. 2018.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Almangush A, Mäkitie AA, Triantafyllou A,
de Bree R, Strojan P, Rinaldo A, Hernandez-Prera JC, Suárez C,
Kowalski LP, Ferlito A and Leivo I: Staging and grading of oral
squamous cell carcinoma: An update. Oral Oncol.
107(104799)2020.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Satgunaseelan L, Allanson BM, Asher R,
Reddy R, Low HTH, Veness M, Gopal Iyer N, Smee RI, Palme CE, Gupta
R and Clark JR: The incidence of squamous cell carcinoma of the
oral tongue is rising in young non-smoking women: An international
multi-institutional analysis. Oral Oncol.
110(104875)2020.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Thomson PJ: Perspectives on oral squamous
cell carcinoma prevention-proliferation, position, progression and
prediction. J Oral Pathol Med. 47:803–807. 2018.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Mumtaz M, Bijnsdorp IV, Böttger F, Piersma
SR, Pham TV, Mumtaz S, Brakenhoff RH, Akhtar MW and Jimenez CR:
Secreted protein markers in oral squamous cell carcinoma (OSCC).
Clin Proteomics. 19(4)2022.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Brands MT, Brennan PA, Verbeek ALM, Merkx
MAW and Geurts SME: Follow-up after curative treatment for oral
squamous cell carcinoma. A critical appraisal of the guidelines and
a review of the literature. Eur J Surg Oncol. 44:559–565.
2018.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Ezhilarasan D, Lakshmi T, Subha M, Deepak
Nallasamy V and Raghunandhakumar S: The ambiguous role of sirtuins
in head and neck squamous cell carcinoma. Oral Dis. 28:559–567.
2022.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Solomon B, Young RJ and Rischin D: Head
and neck squamous cell carcinoma: Genomics and emerging biomarkers
for immunomodulatory cancer treatments. Semin Cancer Biol.
52:228–240. 2018.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Labelle-Dumais C, Schuitema V, Hayashi G,
Hoff K, Gong W, Dao DQ, Ullian EM, Oishi P, Margeta M and Gould DB:
COL4A1 mutations cause neuromuscular disease with tissue-specific
mechanistic heterogeneity. Am J Hum Genet. 104:847–860.
2019.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Shannon P, Hum C, Parks T, Schauer GM,
Chitayat D, Chong K, Shinar S, Blaser S, Moore G and Van Mieghem T:
Brain and placental pathology in fetal COL4A1 related disease.
Pediatr Dev Pathol. 24:175–186. 2021.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Li F, Wang NN, Chang X, Wang SL, Wang LS,
Yao J, Li ZS and Bai Y: Bioinformatics analysis suggests that
COL4A1 may play an important role in gastric carcinoma recurrence.
J Dig Dis. 20:391–400. 2019.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Wang H, Liu Z, Li A, Wang J, Liu J, Liu B,
Lian X, Zhang B, Pang B, Liu L and Gao Y: COL4A1 as a novel
oncogene associated with the clinical characteristics of malignancy
predicts poor prognosis in glioma. Exp Ther Med.
22(1224)2021.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Wang SM, Chen PM, Sung YW, Huang WC, Huang
HS and Chu PY: Effect of COL4A1 expression on the survival of
neoadjuvant chemotherapy breast cancer patients. J Oncol.
2020(5209695)2020.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Xie X, He H, Zhang N, Wang X, Rui W, Xu D
and Zhu Y: Overexpression of DDR1 promotes migration, invasion,
though EMT-related molecule expression and COL4A1/DDR1/MMP-2
signaling axis. Technol Cancer Res Treat.
19(1533033820973277)2020.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Chen C, Méndez E, Houck J, Fan W,
Lohavanichbutr P, Doody D, Yueh B, Futran ND, Upton M, Farwell DG,
et al: Gene expression profiling identifies genes predictive of
oral squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev.
17:2152–2162. 2008.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Wong T and Wiesenfeld D: Oral cancer. Aust
Dent J. 63 (Suppl 1):S91–S99. 2018.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Fan T, Wang X, Zhang S, Deng P, Jiang Y,
Liang Y, Jie S, Wang Q, Li C, Tian G, et al: NUPR1 promotes the
proliferation and metastasis of oral squamous cell carcinoma cells
by activating TFE3-dependent autophagy. Signal Transduct Target
Ther. 7(130)2022.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Bugshan A and Farooq I: Oral squamous cell
carcinoma: metastasis, potentially associated malignant disorders,
etiology and recent advancements in diagnosis. F1000Res.
9(229)2020.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Valastyan S and Weinberg RA: Tumor
metastasis: molecular insights and evolving paradigms. Cell.
147:275–292. 2011.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Yeung KT and Yang J:
Epithelial-mesenchymal transition in tumor metastasis. Mol Oncol.
11:28–39. 2017.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Zeeshan R and Mutahir Z: Cancer
metastasis-tricks of the trade. Bosn J Basic Med Sci. 17:172–182.
2017.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Majidpoor J and Mortezaee K: Steps in
metastasis: An updated review. Med Oncol. 38(3)2021.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Burr R, Gilles C, Thompson EW and
Maheswaran S: Epithelial-mesenchymal plasticity in circulating
tumor cells, the precursors of metastasis. Adv Exp Med Biol.
1220:11–34. 2020.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Gelse K, Pöschl E and Aigner T:
Collagens-structure, function, and biosynthesis. Adv Drug Deliv
Rev. 55:1531–1546. 2003.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Gilkes DM, Chaturvedi P, Bajpai S, Wong
CC, Wei H, Pitcairn S, Hubbi ME, Wirtz D and Semenza GL: Collagen
prolyl hydroxylases are essential for breast cancer metastasis.
Cancer Res. 73:3285–3296. 2013.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Rømer AMA, Thorseth ML and Madsen DH:
Immune modulatory properties of collagen in cancer. Front Immunol.
12(791453)2021.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Hu YZ, Hu ZL, Liao TY, Li Y and Pan YL:
LncRNA SND1-IT1 facilitates TGF-β1-induced
epithelial-to-mesenchymal transition via miR-124/COL4A1 axis in
gastric cancer. Cell Death Discov. 8(73)2022.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Zhang H, Wang Y and Ding H: COL4A1,
negatively regulated by XPD and miR-29a-3p, promotes cell
proliferation, migration, invasion and epithelial-mesenchymal
transition in liver cancer cells. Clin Transl Oncol. 23:2078–2089.
2021.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Wang T, Jin H, Hu J, Li X, Ruan H, Xu H,
Wei L, Dong W, Teng F, Gu J, et al: COL4A1 promotes the growth and
metastasis of hepatocellular carcinoma cells by activating FAK-Src
signaling. J Exp Clin Cancer Res. 39(148)2020.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Jin R, Shen J, Zhang T, Liu Q, Liao C, Ma
H, Li S and Yu Z: The highly expressed COL4A1 genes contributes to
the proliferation and migration of the invasive ductal carcinomas.
Oncotarget. 8:58172–58183. 2017.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Jin Y and Qin X: Comprehensive analysis of
transcriptome data for identifying biomarkers and therapeutic
targets in head and neck squamous cell carcinoma. Ann Transl Med.
8(282)2020.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Reis PP, Tokar T, Goswami RS, Xuan Y,
Sukhai M, Seneda AL, Móz LES, Perez-Ordonez B, Simpson C, Goldstein
D, et al: A 4-gene signature from histologically normal surgical
margins predicts local recurrence in patients with oral carcinoma:
Clinical validation. Sci Rep. 10(1713)2020.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Kuo CL, Lai KC, Ma YS, Weng SW, Lin JP and
Chung JG: Gallic acid inhibits migration and invasion of SCC-4
human oral cancer cells through actions of NF-κB, Ras and matrix
metalloproteinase-2 and -9. Oncol Rep. 32:355–361. 2014.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Pineiro NM, Carneiro A and Crema VO: Rho
GTPases are involved on regulation of cytodifferentiation of SCC-4
oral squamous cell carcinoma cell line: A preliminary study. Asian
Pac J Cancer Prev. 21:3–6. 2020.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Timpl R and Brown JC: Supramolecular
assembly of basement membranes. Bioessays. 18:123–132.
1996.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Fox MA, Ho MS, Smyth N and Sanes JR: A
synaptic nidogen: developmental regulation and role of nidogen-2 at
the neuromuscular junction. Neural Dev. 3(24)2008.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Zhou S, Zhang S, Wang L, Huang S, Yuan Y,
Yang J, Wang H, Li X, Wang P, Zhou L, et al: BET protein inhibitor
JQ1 downregulates chromatin accessibility and suppresses metastasis
of gastric cancer via inactivating RUNX2/NID1 signaling.
Oncogenesis. 9(33)2020.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Urooj T, Wasim B, Mushtaq S, Haider G,
Shah SNN, Ghani R and Qureshi MFH: Increased NID1 expression among
breast cancer lung metastatic women; A comparative analysis between
naive and treated cases. Recent Pat Anticancer Drug Discov.
15:59–69. 2020.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Vaes N, Schonkeren SL, Rademakers G,
Holland AM, Koch A, Gijbels MJ, Keulers TG, de Wit M, Moonen L, Van
der Meer JRM, et al: Loss of enteric neuronal Ndrg4 promotes
colorectal cancer via increased release of Nid1 and Fbln2. EMBO
Rep. 22(e51913)2021.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Xu X, Ban Y, Zhao Z, Pan Q and Zou J:
MicroRNA-1298-3p inhibits proliferation and invasion of glioma
cells by downregulating Nidogen-1. Aging (Albany NY). 12:7761–7773.
2020.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Yuan D, Qian H, Guo T, Ye J, Jin C, Liu X,
Jiang L, Wang X, Lin M and Yu H: LncRNA-ATB promotes the
tumorigenesis of ovarian cancer via targeting miR-204-3p. Onco
Targets Ther. 13:573–583. 2020.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Hsu CW, Chang KP, Huang Y, Liu HP, Hsueh
PC, Gu PW, Yen WC and Wu CC: Proteomic profiling of paired
interstitial fluids reveals dysregulated pathways and salivary NID1
as a biomarker of oral cavity squamous cell carcinoma. Mol Cell
Proteomics. 18:1939–1949. 2019.PubMed/NCBI View Article : Google Scholar
|
